A First-in-Human Phase 1 Dose Escalation and Expansion Study of the Oral CARD11-BCL10-MALT1 Signaling Pathway Inhibitor XL114 in Patients with Non-Hodgkin's LymphomaBert H. O'Neil, Willy Solis, Sofia Vidal-Cardenas,Shailaja Uttamsingh,Abhijeet KumarBlood(2022)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要